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Chapter 1: Introduction
1.1 Background
Stroke Prevalence: Stroke is a leading cause of long-term disability that affects nearly
800,000 people in the United States each year.1 Of those affected by stroke, 50-80% experience
upper extremity (UE) impairment that reduces the individuals’ ability to perform daily tasks
inedependently.2-4 For 40-50% of these individuals, the UE impairment will be chronic and persist
for 6 months or longer post-stroke.4,5 However, the extent of recovery of the paretic UE varies
widely among chronic stroke survivors.
Need for Prognosis: Here, rehabilitation prognosis pertains to the extent of motor function
recovered by the paretic UE (i.e., arm and hand) following therapy. Uncertain prognosis for UE
motor recovery presents a hurdle in developing personalized UE rehabilitation treatment plans for
individual patients. Improved prognosis may guide therapists to set realistic therapy goals related
to UE function and choose the maximally efficient course of treatment for their patients. For
example, for patients predicted to have less UE recovery, therapists may focus on caregiver
training, instruction of compensatory UE techniques, and implementation of adaptive equipment.
For patients predicted to have greater UE recovery, therapists may focus on incorporating the
paretic UE in high-level instrumental activities of daily living, such as meal preparation.
Conventional Predictors: Conventional predictors of post-stroke UE recovery include initial
clinical motor score (e.g. Fugl-Meyer Upper Extremity Assessment), age, sex, presence of a
motor evoked potential, and presence of a somatosensory evoked potential (SEP). 6 Metaanalysis shows that time since stroke and lesion volume do not predict recovery, while the initial
motor score is the most significant predictor.6 However, the effect sizes for such findings have
been shown to be inflated, meaning the strength of the association between initial clinical motor
scores and recovery may be overly optimistic.7,8
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Solution: UE motor recovery may be better predicted by initial neural function (i.e., the
integrity of neural function within the residual neural circuits post-stroke prior to therapy).9 because
initial neural function facilitates neuroplastic changes necessary for motor recovery10 to occur. In
particular, electroencephalography (EEG) may be used to assess neural function and predict
post-stroke UE motor recovery. While other instruments such as magnetic resonance imaging
(MRI)11-15 and transcranial magnetic stimulation (TMS)16 may be used to assess initial neural
function, EEG offers the following compelling advantages.
Advantages

of

EEG:

The

primary

advantage of EEG is that it measures multiple
aspects to provide a complete picture of neural

Spectral Power
Change
Cortico-cortical
Connectivity

function for UE movement (Figure 1), whereas
TMS is limited to measures of corticospinal17
tract integrity. Specifically, the neural circuit for
UE function may be assessed using the

Figure 1

Cortico-muscular
Connectivity

following 4 EEG measures: (1) the ascending
pathway integrity is assessed using SEP,18

Somatosensory Evoked
Potential

which is a direct measure of the sensory signal
from the UE arriving at the primary sensory cortex in the brain,19 (2) communication within the
brain to plan/process/control UE movement is assessed via cortico-cortical connectivity,20 which
is a measure of coherence in electrical activity between brain regions21 involved in the sensory
and motor control of the UE,20,22-28 (3) the motor command for UE movement is assessed via
spectral power change,20 which is a measure of neuronal firing change within the primary motor
cortex during UE movement,20 and (4) the connection between the brain and hand muscle for
generating movement is assessed via cortico-muscular connectivity, which is coherence in
electrical activity between the primary motor cortex and the hand muscle.29
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Additional advantages of EEG are that it provides a direct measure of functional electrical
activity of neuronal assembles in the brain that facilitate neuroplastic changes necessary for motor
recovery to occur,10 as opposed to structural MRI or indirect hemodynamic response in the brain
measured with fMRI. While EEG has poor spatial resolution compared to MRI, it has superior
temporal resolution, capturing millisecond changes in neural activity relevant for function. 30
Furthermore, EEG has no contraindications, while approximately 20% of stroke survivors cannot
undergo MRI or TMS due to contraindications such as metal implants in the body.31 In addition,
EEG is less expensive, can be performed at bedside unlike MRI, and is already used in clinical
practice in the acute inpatient hospital setting.

1.2 Objective
The objective of this study is to determine the prognostic utility of EEG in post-stroke UE
motor recovery. Improved prognosis of post-stroke UE motor recovery is expected to direct UE
rehabilitation goal setting and treatment planning resulting in the most effective course of therapy
for individual patients. Improved prognosis is also expected to enhance therapists’ confidence in
treating patients.9

1.3 Research Question
1. Can EEG improve prognosis of post-stroke upper extremity (UE) motor recovery?

1.4 Specific Aims
Aim 1: To determine the prognostic utility of EEG in stroke recovery via a systematic
review and meta-analysis.
Hypothesis 1: EEG predicts post-stroke recovery outcomes.
5

Aim 2: To establish feasibility of using EEG to predict post-stroke UE motor recovery
from an UE therapy program.
Hypothesis 2: It is feasible to collect EEG and assess post-stroke UE motor recovery
during an UE therapy program.
Aim 3: To determine if EEG predicts post-stroke UE motor recovery following an UE
therapy program.
Hypothesis 3: EEG predicts post-stroke UE motor recovery following an UE therapy
program.
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Chapter 2: Aim 1

Manuscript 1:
The Prognostic Utility of EEG in Stroke Recovery: A Systematic Review and MetaAnalysis
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Abstract
Background: Improved ability to predict patient recovery would guide post-stroke care by helping
clinicians personalize treatment and maximize outcomes. Electroencephalography (EEG) provides
a direct measure of the functional neuroelectric activity in the brain that forms the basis for
neuroplasticity and recovery, and thus may increase our prognostic ability.
Objective: To examine evidence for the prognostic utility of EEG in stroke recovery in a
systematic review/meta-analysis.
Methods: Peer-reviewed journal articles that examined the relationship between EEG and
subsequent clinical outcome(s) in stroke were searched using electronic databases. Two
independent researchers extracted data for synthesis. Linear meta-regressions were performed
across subsets of papers with common outcome measures to quantify the association between EEG
and outcome.
Results: 56 papers were included. Association between EEG and clinical outcomes was seen not
only early post-stroke, but also more than 6 months post-stroke. The most studied prognostic
potential of EEG was in predicting independence in the standard acute stroke care setting. The
meta-analysis showed that EEG was associated with subsequent clinical outcomes measured by
the Modified Rankin Scale, National Institutes of Health Stroke Scale, and Fugl-Meyer Upper
Extremity Assessment (r=0.74, 0.59, and 0.56 from 7, 9, and 7 papers, respectively). EEG
improved prognostic abilities beyond prediction afforded by standard clinical assessments.
However, the EEG variables examined were highly variable across studies, and did not converge.
Conclusions: EEG shows potential to predict post-stroke recovery outcomes. However, evidence
is largely explorative, primarily due to the lack of a definitive set of EEG measures to be used for
prognosis.
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1. Introduction
Stroke is a leading cause of long-term disability in the United States.1,2 Since stroke is
heterogeneous, functional ability and treatment response vary greatly among stroke survivors.3
Currently, due to poor prognostic abilities, clinicians experience difficulty developing
personalized treatment plans that maximize patient outcomes. Improved prognostic ability would
direct treatment planning and provide individual patients with the maximally efficient course of
treatment. Specifically, physicians may utilize patients’ recovery prognosis to determine the most
appropriate discharge setting. Once patients are referred to rehabilitation, therapists may utilize
patients’ recovery prognosis to set appropriate rehabilitation goals and administer individualized
therapy. For example, for patients predicted to require a moderate level of assistance, therapists
may focus on caregiver training, teach compensatory techniques, and introduce adaptive
equipment. Alternatively, for patients with a prognosis of independence, therapists may focus on
restoring function in daily activities, with goals targeted at improving strength and functional
ability. Overall, improved prognostic ability can save both the patient and healthcare system time
and resources while maximizing outcomes.
To aid with prognosis, many studies have investigated potential predictors of post-stroke
outcome including initial clinical assessment, age, sex, time since stroke, and lesion volume. Metaanalysis shows that the initial motor score is the most significant predictor, while time since stroke,
age, sex, and lesion volume do not predict recovery.4 The prognostic utility of the initial clinical
score for recovery, however, has recently been shown to be spurious.5,6 Specifically, the effect
sizes reported for such findings are likely inflated, meaning the strength of the association between
initial scores and recovery may be overly optimistic.5
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Outcome may be better predicted by neural function (i.e., the integrity of neural function
within the residual neural circuits post-stroke).7 In particular, electroencephalography (EEG) may
be used to assess neural function and predict post-stroke recovery. While other instruments such
as magnetic resonance imaging (MRI)8-12 and transcranial magnetic stimulation (TMS)13 are also
used to assess residual neural resources, EEG offers several compelling advantages. First, EEG
provides a measure of direct, functional electrical activity of neuronal assembles in the brain that
facilitate neuroplastic changes necessary for motor recovery14 to occur, as opposed to structural
MRI or indirect hemodynamic response in the brain measured with fMRI.15 While EEG has poor
spatial resolution compared to MRI, it has superior temporal resolution, capturing millisecond
changes in neural activity relevant for function.15 EEG also offers measurement of multiple
aspects, including integrity of the afferent sensory tract16,17 and the corticospinal tract,18 as well as
local19 and network20 electrical activity in the cortex, whereas TMS is limited to measures of
corticospinal21 and corticobulbar22 tract integrity. Furthermore, EEG has no contraindications,
while approximately 20% of stroke survivors cannot undergo MRI or TMS due to
contraindications such as metal implants in the body.23 In addition, EEG costs less than MRI, can
be performed at bedside unlike MRI, and continuous EEG monitoring is already used in clinical
practice for some stroke patients in the acute hospital setting.
Overall, the objective of this study was to perform a systematic review and meta-analysis
to determine the prognostic utility of EEG for post-stroke outcome. Qualitative synthesis of
evidence exists in a recent review.24 To further this knowledge, the present paper provides a
quantitative synthesis of evidence with a meta-analysis. In addition, the previous review24
examined 25 papers exclusive to acute/subacute stroke (<6 months post-stroke) in 4 outcome
domains (i.e., mortality, function, epilepsy, cognition). In contrast, the present paper synthesized
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56 papers pertaining to both acute/subacute and chronic stroke (≥6 months post-stroke) in 9
outcome domains (i.e., independence, stroke severity, upper extremity, speech, whole body
sensorimotor, balance/gait, cognition, mortality, level of consciousness). It is important to consider
prognosis in the chronic phase given accumulating evidence showing that neuroplasticity and
subsequent recovery extends beyond 1-year post-stroke.25 Through comprehensive qualitative and
quantitative synthesis of the literature, we aim to provide an overview of the prognostic potential
of EEG in predicting post-stroke outcomes.

2. Methods
2.1 Search Strategy
We followed the PRISMA guidelines for systematic reviews and meta-analyses26 to
examine the prognostic utility of EEG in stroke outcome. A literature search was conducted in
PubMed (Medline), Scopus, and CINAHL databases. The search terms used were stroke and
electroencephalography or EEG. We developed our search strategy based on consultation with a
medical librarian and consideration of the literature. The search included papers published between
1965 and 2019 and was last searched on January 10, 2019.

2.2 Inclusion and Exclusion Criteria
2.2.1 Systematic Review
I. Publication
a. Inclusion:
i. Peer-reviewed journal paper.
ii. Written in English.
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II. Study design
a. Inclusion:
i. Papers that acquired EEG for clinical and/or research purposes.
ii. Papers that examined the relationship between baseline EEG and
subsequent stroke related clinical outcome measures.
iii. Papers that reported statistical analysis results for prognosis and/or
provided data sufficient for independent statistical analysis for
prognosis.
b. Exclusion:
i. Meta analyses, reviews, clinical guidelines, case studies,
commentaries, and trial protocols.
ii. Papers that did not measure EEG.
iii. Papers that did not include a clinical outcome measure.
III. Participant characteristics
a. Inclusion:
i. Study participants had a stroke(s) of any type.

2.2.2 Meta-Analysis
I. Outcome measure
a. Inclusion:
i. Outcome measure common in at least five papers.
b. Exclusion:
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i. Papers that utilized a modified outcome measure (e.g.,
dichotomization, proportion, partial items).
II. Statistics
a. Exclusion:
i. Papers did not provide relevant statistics or data needed to calculate
relevant statistics, or authors did not provide data upon request.

2.3 Screening
Papers were screened by the primary and the senior author independently. Papers were
initially screened based on the title and abstract. For papers that met the inclusion criteria based
on the title and abstract, full-text papers were obtained and a subsequent screening was performed
to determine if the inclusion criteria were met. The senior author completed 30% of the initial
abstract screening and 32% of the full-text screening. In cases of discrepancy, resolution was found
by a joint re-review of the paper.

2.4 Analysis for Systematic Review
Study characteristics were extracted from the selected papers, including patient
characteristics, time since stroke, medical treatment, EEG protocol, EEG variable, outcomes, and
findings. In addition, methodological quality of the papers was determined according to the
modified Downs and Black Checklist.27-30 The modified version of the checklist27-30 was used due
to the limited number of experimental intervention studies included in this review. Two
independent raters determined quality of the papers included in the meta-analysis and one of the
raters determined the quality of all remaining papers included in the systematic review.
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Findings were classified as positive or negative based on the following criteria. (1)
Findings with p<0.05 were counted as positive and findings with p>0.05 were considered as
negative for regressions, correlations, odds ratios, t-tests, and ANOVAs. (2) In cases of multiple
regression and/or ANOVA with other predictors (e.g., initial clinical score), the finding was
considered as positive if EEG contributed to the statistical model. (3) If a p-value was not provided,
correlation coefficients or predictive values ≥0.6 were considered as positive and findings with
<0.6 were considered as negative.31 Papers were then classified as “positive” if they presented only
positive findings for EEG prognosis, “negative” if they presented only negative findings, and
“mixed” if they presented both positive and negative findings.
The results of papers were qualitatively examined against study characteristics including
sample size, time post-stroke at EEG and at outcome, EEG variable, number of EEG electrodes,
outcome domains, and quality score, to investigate the association between study characteristics
and prognostic results.

2.5 Meta-Analysis Method
For each paper, we extracted a correlation coefficient between baseline EEG and a
subsequent outcome measure. When an odds ratio was provided instead of a correlation, a
transformation to the scale of a correlation coefficient Yule’s Q32 was applied. Two papers33,34 that
examined the same sample of subjects were treated as a single paper in the analysis. Six papers3338

reported EEG and/or outcome measure scores at two or more timepoints. Therefore, we included

data at each timepoint. For 13 papers that did not provide the data needed to calculate relevant
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statistics, the authors were contacted via email. One author responded and provided additional data
from which correlation was calculated and included in the meta-analysis.
The correlation coefficient of each paper was then transformed using Fisher transformation
for normal distribution.39 To estimate an average association between EEG and clinical outcome,
a linear meta-regression was performed for each outcome, adjusting for sample size and study
quality. Weighted sample size (=√[n/total n of included papers]) and weighted quality scores
(=√[score/max possible score]) were used in the analysis. To account for multiple EEG and/or
outcome measure times within a single paper, study ID was included in the analysis as a random
effect for all models. Time of EEG, outcome time, time between EEG and outcome, and time poststroke were adjusted for but did not significantly contribute to any of the regression models and
were removed.

3. Results
3.1 Systematic Review
Search results
Results of the literature search and screening are summarized using the PRISMA 2009
flow diagram in Figure 1. A total of 56 papers met inclusion criteria and were synthesized for the
systematic review. These 56 papers included a total of 2,947 participants’ data, with the average
age of participants in each paper ranging from 45 to 75 years. The majority of the papers were
published in the last decade (Figure 2A). Of 56, 28 papers reported mixed results (i.e., both positive
and negative), 24 only positive, and 4 only negative (Figure 2A). The detailed study information
including characteristics of patients, EEG, outcome measures, and quality scores of each paper can
be found in supplement A.
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Time since stroke
The majority of the papers assessed EEG for prognosis within one-month post-stroke
(Figure 2B). Across all times post stroke, the majority of studies found positive or mixed results
for the predictive ability of EEG. Interestingly, negative findings were not associated with later
time post stroke, and the proportion of papers with positive findings did not decrease with
increasing time post stroke (Figure 2B). This observation remained despite the fact that time post
stroke stretched to 1-8 years post stroke in the chronic papers.
Type of stroke
Of the 56 papers, 37 included only ischemic stroke and 1936,40-57 included both ischemic
and hemorrhagic stroke. However, of those that included both types of stroke, no papers compared
prognosis between ischemic and hemorrhagic stroke. Thus, direct comparisons between stroke
type could not be made. However, 2 papers compared ischemic stroke subtypes.58,59 Specifically,
one study found that for posterior circulation syndrome, EEG within 3 days post stroke was
associated with 1-week stroke severity measured by the National Institutes of Health Stroke Scale
(NIHSS) but not independence measured by the Modified Rankin Scale (MRS), while the opposite
was seen for lacuna syndrome.58 The other study found that EEG within a week post stroke was
predictive of 1-year MRS for both cortical and lacunar syndrome.59
Treatment
Of 50 papers with mean EEG time <2 months post stroke, 48 papers followed standard
care, which encompassed inpatient hospitalization and/or inpatient rehabilitation therapy. The
other 2 papers used a standardized treatment in which all patients received the same dose of a
particular treatment (auditory discrimination training60, mechanical endovascular therapy61)
(Figure 3). The other 6 papers with mean EEG time ranging 3 months to 8 years post stroke used
18

a

standardized

upper

extremity

treatment

including

standardized

manual

motor

rehabilitation40,41,43,62 visuomotor tracking training42, and robot assisted therapy.44

EEG protocol
EEG was obtained for both clinical51,63-66 and research33-38,40-50,52-62,67-89 purposes. Of 50
papers with mean EEG time <2 months post stroke, 36 papers obtained resting EEG, while 14
papers obtained EEG response to stimuli, the majority being electrical nerve stimulation in 9
papers (Figure 3). The other 6 papers with mean EEG time >2 months post stroke obtained EEG
during resting (n=3) and upper limb movement (n=3).

EEG variables & Outcome
EEG variables used varied considerably across papers. Thus, EEG variables were grouped
into power, event related potential, epileptiform, connectivity, and dipole-based EEG variable
types (Figure 3). Outcome measures also varied considerably across papers, and were, therefore,
grouped into outcome domains of independence, stroke severity, upper extremity, speech, (whole
body) sensorimotor, balance/gait, cognition, mortality, and level of consciousness (Figure 3).
The positive, mixed, and negative findings were spread across EEG variable types and
outcome domains (Figure 4). Nearly two-thirds of papers assessed power (e.g., brain wave
oscillation symmetry, delta to alpha power ratio, peak frequency). As such, power had the most
positive and most negative findings. The majority of papers (n=53 papers) examined a single EEG
variable type. Thus, direct comparison of prognostic potential across multiple EEG variable types
is limited.

19

The most assessed outcome domain was independence (n=20 papers, e.g., MRS), followed
by stroke severity (n=17 papers, e.g., NIHSS). Independence also had the largest number of papers
with positive findings (Figure 4).

Quality score, sample size, EEG to outcome time, number of EEG electrodes
The quality score ranged from 7 to 14, with a mean+SD=11±2 points, out of 16 points.
Twenty six papers were found be of “good” quality (≥71%), 25 “fair” (54-70%), and 5 “poor”
(≤53%).27,90 The poor quality was due to absence of variance estimates and/or actual probability
values (e.g., reporting <0.05 rather than exact p-values) and absence of description or adjustment
for confounding variables, such as age and initial clinical score of patients. Poor quality was
associated with earlier publication time, as 4 of the 5 poor quality papers were published between
1982 and 1994. Detailed quality score information including the number of points received on
each item of the checklist and the total score for each paper can be found in supplement B.
Sample size ranged from 652 to 35173 participants (median=36). EEG to outcome time
ranged from 4 days66 to 3 years84 (median=2 months). The number of electrodes used ranged from
148 to 256,41,42 with 19 being the most used.33,34,60,65,66,71,75,76,79-81,85
The prognosis results of each paper are plotted against quality score, sample size, EEG to
outcome time, and number of EEG electrodes in Figure 5. Papers with negative findings appear to
have a combination of a (i) long time period between EEG and outcome measure (e.g., 2-3 years),
(ii) low quality score, (iii) low sample size, and (iv) low number of EEG electrodes (Figure 5).
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Prognosis beyond conventional predictors
A total of 21 papers examined if EEG enhanced prognostic ability more than prognosis by
the conventional predictor of baseline clinical score. Fourteen papers found positive results.
Specifically, the examined EEG variable(s) significantly explained variance in outcome after
controlling for initial clinical score in 6 papers.48,54,62,64,80,85 In 3 papers, EEG further separated
patients with good or poor prognosis after the consideration of the initial clinical score.38,49,59 In 5
papers, EEG correlated with outcome while initial clinical score did not.41,47,65,78,86 Mixed results
were found in 6 papers, where EEG enhanced prognostic ability of conventional predictors only
for some EEG variables,76,81 EEG time,33 subgroup,71 outcome domain,72 and analysis method.58
A negative result was found in 1 paper, in which only cerebral blood flow, not initial clinical score
or EEG, predicted 3-year outcome.84

Explorative investigation
It was evident during the review that the majority of papers involved exploratory
investigation. Specifically, 25 papers reported prognostic results for each of multiple EEG
variables (e.g., simple correlations), including not only different EEG variable types (e.g., power,
connectivity), but also multiple frequency bands (e.g., delta, theta, alpha, beta, gamma), multiple
brain regions (e.g., ipsilesional, contralesional), multiple parameters (e.g., amplitude, latency,
relative vs. absolute power, power ratio, dipole x, y, and z coordinates) and different tasks during
EEG (e.g., eyes open vs. close, movement preparation vs. execution). In addition, 15 papers used
an approach to statistically select a subset of multiple EEG variables for best prognostic results
(e.g., stepwise regressions). Further, many papers examined prognostic results for multiple
outcome times (n=6) and multiple outcome domains (n=11).
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3.2 Meta-Analysis
Search results
Results of the meta-analysis screening are summarized using the PRISMA 2009 flow
diagram in Figure 1. Of the 56 papers included in the systematic review, 21 papers met the
inclusion criteria and were synthesized for the meta-analysis. Quality scores ranged from 9 to 14,
with mean+SD=12±2 out of 16 points. Twelve papers were found be of “good” quality (≥71%)
and 9 “fair” (54-70%) quality.27,90 The outcome measures examined were: (1) MRS91 which
measures the degree of disability/dependence in daily activities, (2) NIHSS92 which measures
stroke severity, and (3) Fugl-Meyer Upper Extremity Assessment (FMUE)93 which measures
upper extremity motor impairment.

Correlation between EEG and MRS
Seven papers utilized MRS as the outcome measure. These papers presented 13 EEG and
MRS correlations (Figure 6A) in a total of 186 participants. All papers assessed the EEG variable
type of power. Linear meta-regression of the correlation between baseline EEG and subsequent
MRS demonstrated a strong31 adjusted effect of 0.74 (95% CI: 0.66-0.80).

Correlation between EEG and NIHSS
Nine papers utilized NIHSS as the outcome measure. These papers presented 12 EEG and
NIHSS correlations (Figure 6B) in a total of 295 participants. They included multiple EEG variable
types, including power and connectivity. Linear meta-regression of the correlation between
baseline EEG and subsequent NIHSS demonstrated a moderate31 adjusted effect of 0.59 (95% CI:
0.50-0.66).
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Correlation between EEG and FMUE
Seven papers utilized FMUE as the outcome measure. These papers presented 9 EEG and
FMUE correlations (Figure 6C) in a total of 187 participants. They included multiple EEG variable
types, including power, connectivity, and event related potential. Linear meta-regression of the
correlation between baseline EEG and subsequent FMUE demonstrated a moderate31 adjusted
effect of 0.56 (95% CI: 0.45-0.65).

4. Discussion
Many papers have examined the prognostic utility of EEG in post-stroke outcome (56
papers for a total of 2,947 participants). There has been a steep increase in the number of papers
examining the prognostic utility of EEG in the last decade. This increase may be in part due to
improvement in the computing resources to analyze EEG efficiently and in novel ways (e.g.,
connectivity, dipole/source analysis), along with the emergence of high-density EEG systems.
The majority of papers (52/56, 93%) showed all or some positive prognostic potential of
EEG for post-stroke outcomes. Main observations are detailed as follows. First, prognostic
potential was evident at all times post-stroke. While the majority of research has focused on
prognosis within a few months post-stroke, there is evidence for chronic stroke patients with
mean time post-stroke ranging from 11 months40 to 8 years44 that EEG is associated with
improvement after a subsequent rehabilitation treatment. This evidence is aligned with general
evidence of neuroplasticity in chronic stroke.94,95 This finding is encouraging for the clinical use
of EEG for prognosis and also has implications for participant selection in stroke recovery
research studies which includes chronic stroke survivors exclusively in many cases. Stroke
recovery research studies often result in findings that a treatment works best for a subset of the
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study sample. It is possible that EEG would be a useful tool to provide information to explain
subsets of non-responders or even to be used as inclusion criteria.
Second, direct comparisons were not made between ischemic and hemorrhagic stroke
types. While initial improvement is greater for hemorrhagic stroke compared to ischemic stroke,
the time course of recovery does not differ between the two stroke types from 3 months poststroke.96 Despite the difference in etiology and initial severity level, response of the brain to the
insult as captured by EEG may be relevant for recovery for both stroke types, although this needs
to be empirically tested.
Third, among outcome domains, independence was most studied with most positive
findings and no negative findings (n=14 only positive, 6 mixed, 0 negative findings). Metaanalysis including 7 papers also supports the strong relationship between EEG and MRS. All
papers that examined independence as an outcome were in acute/subacute stroke, with EEG
performed on average 6 days post stroke (ranging from a few hours to a month), and outcome
measured on average 4 months post stroke (ranging from a week to a year). Therefore, the
translational potential of this evidence to standard acute/subacute stroke care is high, as the
majority of the evidence is directly from that setting, involving EEG recording while patients
rested.
While some ability of EEG to predict outcomes was seen for all outcomes studied, the
results from other outcomes, such as upper extremity movement, speech, balance/gait, and
cognition, were mixed. For all outcomes, besides sensorimotor, there was more evidence to
support the predictive ability of EEG than evidence to refute it. In general, more research with
methodological rigor is needed to determine the predictive ability of EEG for these outcomes.
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Third, in over 95% of studies, EEG was able to increase prognostic ability compared to
using the conventional predictor of initial clinical score alone. This is a critical point in the
potential translation of EEG to routine clinical practice. The addition of EEG, while non-invasive,
can be cumbersome and adds to cost of care. Evidence that prognostic ability is improved from
what can be attained from standard of care is a critical factor in advocating for the addition of
routine EEG in post-stroke patients. The practical extent of the consequences of better prognostic
ability will need to be explored. It will be important for clinicians and hospital/clinical managers
to ultimately realize a quality and/or cost benefit to the addition of prognostic EEG.
Lastly, prognostic potential was likely obscured due to methodological constraints.
Variables such as EEG to outcome time, sample size, and number of EEG electrodes used may all
contribute to differences in study results. The variety of EEG measures and lack of standardization
also may mask results and hinders comparability of study outcomes. In addition, many studies had
fair or poor quality evaluations due in large part to data not being fully reported; some quality
issues were methodological in nature and may have influenced study results.
Evidence regarding prognostic utility of EEG is largely explorative. The majority of papers
were exploratory in nature and did not have a priori hypothesized EEG variable(s) for prognosis.
This explorative nature explains the large number of papers with mixed results due to the variety
of EEG measures used. This may also explain the moderate relationships between EEG and
outcomes such as the NIHSS or FMUE. In general, there is emerging evidence that EEG has the
potential to inform clinical decision-making and guide individualized treatment. However,
consensus on the best EEG biomarker is needed for clinical translation to occur.
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Limitations
Due to publication bias, the prognostic value found in this review may be elevated.
However, such bias may have been mitigated since EEG prognosis is typically investigated as a
secondary analysis in many papers. In addition, we were conservative in categorizing the results
of each paper. Some papers concluded a positive prognostic result, while they were regarded as
negative in this review based on the criteria described in the method section. Some papers
hypothesized prognosis for one EEG variable and reported negative results for other EEG
variable(s) as a negative control, which added to the number of negative findings in this review.
Some papers had an objective different from prognosis and happened to report correlations
applicable to prognosis. Those results added to the negative results in this review, although these
papers may not have chosen an EEG variable best for prognosis. The conservative approach used
in this review was to identify a robust biomarker of outcome.
The number of papers included in the meta-analysis was reduced, because some papers
applied outcome measures differently (e.g., dichotomization). This review did not include papers
that were published in languages other than English.

5. Conclusion
Many studies examined the prognostic utility of EEG in post-stroke outcome in the recent
decade. Prognostic evidence was seen at all times post-stroke, with mean time post-stroke ranging
from immediately after the stroke61 to 8 years.44 The most studied prognostic potential of EEG is
in predicting independence in the standard acute/subacute stroke care setting. This finding is also
supported by the strong relationship between EEG and MRS found in the meta-analysis.
Furthermore, there is evidence that EEG improves prognostic ability beyond the conventional
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predictor of the initial clinical score. However, evidence regarding the prognostic utility of EEG
is largely explorative, with many EEG measures used, primarily due to the lack of a definitive set
of best EEG variables to use for prognosis. With continued advancement in computing capacity
that enables source imaging and analysis efficiency, exploration of EEG biomarkers is expected
to continue. In summary, EEG shows potential to improve post-stroke prognostic ability and
inform clinical management, with a need to identify the best EEG measures for prognosis.
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Figure 2. The number of papers published examining prognostic utility of EEG for post-stroke
outcome over the years (A) and mean EEG times (B). The histograms shows the number of
papers for each time period that reported (i) only positive, (ii) only negative, and (iii) mixed (i.e.,
both positive and negative) findings for EEG-based prognosis of post-stroke outcome. The upper
limit of the bin is noted on the horizontal axis (e.g., bins=1981-1990, … , 2011-2020 in A, 0-1
day, >1 to 3 days, … in B). The last bar in B includes papers with EEG time ranging from 1 to 8
years post stroke. One paper with mixed findings did not report the exact EEG time,45 thus is not
included in B.
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Figure 3. Distribution of papers per study characteristics, including time since stroke, EEG protocol, EEG variable type, outcome
domain, and outcome measure shows a lack of uniformity.
42
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Figure 4. Distribution of outcome domains and EEG variable types examined. Papers that
reported (i) only positive, (ii) only negative, and (iii) mixed findings for EEG-based prognosis of
post-stroke outcomes are presented in stacked bars. Papers that examined multiple outcome
domains and/or EEG variable types are presented for each result. In addition to the 4 papers that
showed negative findings in the previous figure,46,51,84,87 3 papers reported negative findings in
only some of the multiple outcome domains35,89 or some of the multiple EEG variable types
examined.86
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Figure 5. Distribution of the quality score, sample size, EEG to outcome time, and number of
EEG electrodes used (denoted by the marker diameter) across papers. Papers that reported (i)
only positive, (ii) only negative, and (iii) mixed findings for EEG-based prognosis of post-stroke
outcome are presented with the solid, segmented, and dotted lines, respectively. Papers that
examined multiple outcome time points are presented for all time points (e.g., one study36
reported negative findings for 2 months but positive findings for 6 and 12 month outcomes).
Papers that did not report information on EEG or outcome times are not included in this figure.
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Figure 6. Forest plots showing correlation coefficients between EEG and outcome with 95%
confidence interval for MRS (A), NIHSS (B), and FMUE (C).
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Abstract
Background: Subthreshold vibratory stimulation to the paretic wrist has been shown to prime
the sensorimotor cortex and improve 2-week upper extremity (UE) therapy outcomes.
Objective: To determine feasibility, safety, and preliminary efficacy of the stimulation over a
typical 6-week therapy duration.
Methodology: Four chronic stroke survivors received stimulation during 6-week therapy.
Feasibility/safety/efficacy were assessed at baseline, post-therapy, and 1-month follow-up.
Results: For feasibility, all participants wore the device throughout therapy and perceived the
stimulation comfortable/safe. Regarding safety, no serious/moderate intervention-related adverse
events occurred. For efficacy, all participants improved in Wolf Motor Function Test and UE use
in daily living based on accelerometry and Stroke Impact Scale. Mean improvements at posttherapy/follow-up were greater than the minimal detectable change/clinically important
difference and other trials with similar therapy without stimulation.
Conclusion: The stimulation was feasible/safe for 6-week use. Preliminary efficacy encourages a
larger trial to further evaluate the stimulation as a therapy adjunct.

Keywords: Stroke rehabilitation, upper extremity, paresis, subliminal stimulation, physical
stimulation, patient safety
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Introduction
Stroke is a leading cause of long-term disability in the United States (Virani et al., 2020).
Upper extremity (UE) impairment affects 65% of stroke survivors at 6 months post-stroke
(Dobkin & Carmichael, 2016). UE impairment limits stroke survivors’ ability to perform
functional tasks, thus reducing independence (Stewart & Cramer, 2013). Given limited time and
resources allotted for therapy (Lynch et al., 2017). post-stroke treatment must be optimized to
maximize recovery.
One approach to enhance motor recovery is the use of sensory stimulation as a therapy
adjunct (Conforto et al., 2018). Sensory stimulation facilitates changes in the primary motor
cortex (Baker, 2007; Schabrun et al., 2012) and associated motor output (M. Ridding & J.
Rothwell, 1999) via direct neuronal projections from the sensory to motor areas (Chen & Ashby,
1993; Jenner & Stephens, 1982). As such, meta-analysis showed that application of sensory
stimulation immediately prior to therapy enhanced UE motor recovery more than therapy
without stimulation (Conforto et al., 2018). However, the existing sensory stimulation method
requires patients to remain in a sedentary position for 2 hours while receiving stimulation (Bastos
Conforto et al., 2010; Carrico, Chelette, II, et al., 2016; Carrico, Chelette, Westgate, et al., 2016;
Celnik et al., 2007; Conforto et al., 2007) and the effect diminishes once the stimulation is
removed (Kaelin‐Lang et al., 2002; Smith & Brouwer, 2005).
To address these limitations, a novel sensory stimulation was recently developed.
Specifically, the new stimulation uses a wearable wristband to apply subthreshold randomfrequency vibratory stimulation to the paretic wrist during therapy. Thus, the effect of the
stimulation may remain potent during therapy tasks because it is delivered continuously during
therapy. In addition, the new stimulation does not interfere with therapy tasks because the device
is compact and wearable and the stimulation is imperceptible. Using this stimulation eliminates
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the need for patients to receive stimulation in a sedentary position prior to therapy. Therefore, the
new stimulation may offer advantages that might promote translation to clinical practice.
Preliminary studies have shown that the new stimulation primes the sensorimotor cortex
for the hand (Seo et al., 2015; N. J. Seo, K. Lakshminarayanan, et al., 2019). Specifically,
sensory processing activity in the sensory cortex measured by electroencephalography increased
when the stimulation was applied (Seo et al., 2015), explaining enhanced sensation with the
stimulation in chronic stroke survivors (Enders et al., 2013). Since sensory input affects motor
output (M. C. Ridding & J. C. Rothwell, 1999), the new stimulation has also been shown to
increase brain activity for hand grip tasks (N. J. Seo, K. Lakshminarayanan, et al., 2019),
explaining improved hand grip performance with the new stimulation in chronic stroke survivors
(Seo et al., 2014). Thus, the new stimulation may have a potential to facilitate neural plasticity
and recovery of hand function post-stroke. A 2-week pilot randomized controlled study showed
that use of this stimulation during task-practice therapy increased UE motor function more than
therapy without stimulation (N. J. Seo, M. L. Woodbury, et al., 2019).
However, use of this stimulation over a longer treatment duration typical in standard
rehabilitation, such as 6 weeks, has not been examined. Clinicians and peer scientists have
expressed serious concerns that longer exposure to the stimulation may cause patients to become
desensitized to UE sensory input and/or dependent on the stimulation, resulting in worse sensory
and/or motor function. Thus, it is critical to examine whether patients exhibit deterioration of
sensation with safety concerns and a lack of motor improvement after 2 weeks of treatment,
possibly resulting in patients’ refusal of the stimulation. Therefore, the purpose of this study was
to determine feasibility, safety and preliminary efficacy of using this stimulation during a typical
6-week therapy duration.
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Materials and Methods
Participants
The study protocol was approved by the Institutional Review Board. All participants
provided written informed consent. Participants were included if they were adults at least 6months post-stroke with moderate UE impairment (Fugl-Meyer Assessment Upper Extremity
score 19-47) (Woodbury et al., 2013) with the ability to participate in UE therapy. Participants
were excluded if they had (1) complete UE deafferentation, (2) UE rigidity, (3) botulinum toxin
injection in the paretic UE within 3 months (Setler, 2002) prior to/during enrollment, (4)
brainstem stroke, (5) comorbidity, such as orthopedic conditions, peripheral neuropathy of the
hand, or compromised skin integrity of the wrist, (6) concurrent UE therapy, or (7) language
barrier/cognitive impairment that precluded following 3-step instructions and/or providing
consent.

Experimental Design
A single-arm pilot study was conducted. All participants received in-lab task-practice
therapy with an occupational therapist while wearing a stimulation device on the paretic wrist
(figure 1). Therapy was approximately 2 hours/session, 3 sessions/week for 6 weeks, for a total of
18 sessions, resembling a typical outpatient therapy schedule.

[Figure 1 near here]

Therapy followed a standardized manual with activities to address manual dexterity. The
manual (N. J. Seo, M. L. Woodbury, et al., 2019) was developed by experienced therapists based
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on the EXCITE trial (Wolf et al., 2006) manual and Task Specific Practice (Lang & Birkenmeier,
2014). Each session, participants practiced 2 in-hand manipulation tasks and 2 tasks involving
reaching to grasp/place objects. The therapist and participant collaboratively selected tasks
relevant to the participant’s daily living. To standardize therapy dosage, participants completed
300 UE movement repetitions per session (75 per task). The manual defined a repetition for each
task to ensure consistency in counting repetitions. Tasks were adjusted to achieve a difficulty level
that was “just-right” for each participant. The right difficulty level was achieved by changing the
weight, size, shape, and location of the object, using adaptive materials (e.g., nonslip mat to prevent
items from moving) as needed, and adjusting task complexity, instruction, movement speed, and
accuracy. Participants were also encouraged to practice the tasks in-home and use the paretic UE
in daily activities.
The stimulation device (figure 1) was composed of a vibrator (C-3 Tactor, EAI,
Casselberry, FL) and MP3-playing watch (Amazon). The device delivered random-frequency
vibration (with white noise signal low-pass filtered at 500 Hz) to the wrist at 60% of the sensory
threshold (i.e., imperceptible to the participant), continuously throughout each therapy session.
These vibration parameters were selected because they yielded consistent, reproducible,
statistically significant improvement in hand function in previous studies (Enders et al., 2013;
Lakshminarayanan et al., 2015; Seo et al., 2014; Seo et al., 2015; N. J. Seo, M. L. Woodbury, et
al., 2019). The participants’ sensory threshold was determined at the beginning of each therapy
session by increasing or decreasing the vibration intensity until the participant verbally indicated
they could or could not perceive the vibration, respectively (Ehrenstein & Ehrenstein, 1999; N. J.
Seo, M. L. Woodbury, et al., 2019). The stimulation device was not worn outside therapy.
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Feasibility
First, the therapist observed whether the participants wore the device and monitored
participants’ reactions throughout therapy sessions. Second, participants’ perceived comfort and
safety in receiving the stimulation from the device during therapy were obtained on a 7-point
Likert scale (1=strongly agree, 7=strongly disagree) post-intervention. In addition, to determine
if the vibration was indeed imperceptible, the therapist asked participants if they felt vibration
after each therapy session.

Safety
Adverse events (AEs) were identified according to the criteria/schedule in table 1. AEs
were evaluated for severity (US Department of Health and Human Services, 2017) and
relatedness to the intervention (NINDS, 2017). The severity and relatedness categorizations were
approved by the Data and Safety Monitoring Board.

[Table 1 near here]

Preliminary Efficacy
The effect of the intervention on motor function was assessed using the Wolf Motor
Function Test (WMFT) (Wolf et al., 2001) time and Box and Block Test (BBT) (Chen et al.,
2009). Translation of improved motor function to paretic UE use in daily living was assessed
using the objective accelerometer measure (Waddell et al., 2017), patient-perceived measure of
the Stroke Impact Scale (SIS) hand and activities of daily living (ADL) subscales, and selfreported benefits. For accelerometers, participants wore an ActiGraph GT9X Link (ActiGraph,
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Pensacola, FL) on the paretic wrist outside therapy for 3 days. The total number of hours per day
that the paretic UE was active was computed. All assessments were administered at baseline,
post (within 1-week after the last therapy session), and 1-month follow-up. Additionally, WMFT
and accelerometer were assessed after each week of therapy to examine the trend of change over
time.
To ensure reliability, WMFT and BBT were videotaped and scored by blinded raters
trained on standard scoring procedures (Mathiowetz et al., 1985; Taub et al., 2011). Videos were
coded so raters did not know the time of the assessment (before, when during treatment, or when
after treatment). Inter-rater and intra-rater reliabilities were assessed using Spearman correlation
using scores from all assessment times and subjects. Interrater reliability was 0.999 for WMFT
and 1.0 for BBT. Intra-rater reliability was 1.0 for both WMFT and BBT.
Changes in UE motor function and use in daily living were examined for individual
participants and compared to the minimum detectable change (MDC) and minimal clinically
important difference (MCID) to gauge whether they were beyond measurement error and
clinically relevant, respectively. In addition, week-to-week changes in WMFT and accelerometer
data were visually examined for any trend over time. Furthermore, the changes were compared to
other published trials with similar manual therapy but without stimulation. This historical
comparison was to gauge if the addition of stimulation to therapy might improve UE outcomes
more than therapy without stimulation. Specifically, WMFT, SIS, and accelerometer data were
historically compared because those measures were reported in previous trials with similar
manual therapy.
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Results
Participants
Four participants completed the study. Participants had the mean age of 69 (SD=6) years,
mean time post-stroke of 6 (SD=7, range=1.6-16) years, and mean baseline FMUE score of 33
(SD=12, range=22-46).

Feasibility
All participants completed 18 therapy sessions while wearing the stimulation device, with
no requests to remove it at any time, as observed by the therapist. Participants perceived that the
stimulation was comfortable (median=2, range=1-2 on the 7-point Likert scale) and safe
(median=2.5, range=1-4) during therapy. The vibration remained imperceptible, as all
participants reported that they did not feel vibration during any therapy session.

Safety
No serious AEs were observed throughout the study. No moderate AEs related to the
intervention were observed. Only one participant experienced mild AEs with reasonable
possibility of being related to the intervention, which were skin irritation on the paretic elbow
during one therapy session and increased Monofilament scores on the 5th digit pad at post and
follow-up (3.61) compared to baseline (2.44). All AEs are detailed in supplement 1.

Preliminary Efficacy
Changes in UE Motor Function
All participants improved in WMFT time at post and follow-up compared to baseline
(figure 2A). Mean improvement in WMFT time was 10 sec (SD=7) at post and 14 sec (SD=11)
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at follow-up. These improvements in WMFT time were beyond MDC (0.7 (Fritz et al., 2009) or
4.36 (Lin et al., 2009) secs). However, mean improvement in BBT did not exceed MDC (5.5
blocks) (Chen et al., 2009) (figure 2B).

[Figure 2 near here]

Changes in UE Use in Daily Living
All participants moved their paretic UE more in daily living at post and follow-up
compared to baseline, as seen by increased hours of UE use from accelerometers (figure 2C).
All participants also improved on SIS-hand (figure 2D) and 3 of 4 improved on SIS-ADL (figure
2E) at post and follow-up compared to baseline. The mean increase for SIS-hand was 21 and 18
at post and follow-up, which was above MCID (17.8 (Lin et al., 2010)). For SIS-ADL, the mean
increase was 15 and 18 at post and follow-up, which was above MCID at post and follow-up and
MDC at follow-up (5.9 (Lin et al., 2010) and 17.3 (Lin et al., 2010), respectively). Furthermore,
all participants had self-reported benefits in using the paretic UE in daily living, as summarized
in supplement 2.

Week-to-Week Changes
A trend of continuous improvement over the study period was observed for UE motor
function measured by WMFT time (figure 3A). A similar trend was observed also for UE use in
daily living as measured by the active hours for the paretic UE using the accelerometer (figure
3B).
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[Figure 3 near here]

Comparison to Other Trials
Mean UE improvements were greater in our study than those in other trials using similar
manual therapy without stimulation. Specifically, mean improvement in WMFT time was greater
in our study than in other large trials (Lo et al., 2010; Winstein et al., 2016) (figure 4A). In
addition, mean increase in hours of paretic UE use from accelerometers was higher in our study
than in another trial (Waddell et al., 2017) at post (24% vs. 4% increase, or 35 vs. 10 min more
per day from baseline, only post data available in the other trial (Waddell et al., 2017)).
Similarly, mean increases in SIS-hand and SIS-ADL were higher in our study than in other trials
(Birkenmeier et al., 2010; Lang et al., 2016) (figure 4B-C, only post data available for one trial
(Lang et al., 2016)).

[Figure 4 near here]

Discussion
This study investigated feasibility, safety, and preliminary efficacy of using subthreshold
random-frequency vibratory stimulation during 6-week task-practice therapy. This study extends
the previous 2-week study (N. J. Seo, M. L. Woodbury, et al., 2019) in the following ways.

Feasibility/Safety Over a Longer Therapy Duration of 6 Weeks
First, we found that the stimulation was feasible and safe to use over a longer therapy
duration of 6 weeks. For safety, the mild skin irritation experienced by one participant likely
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resulted from the elbow rubbing on an armrest, which could occur during any therapy
intervention or in daily living. Increased Monofilament scores may have been influenced by the
little to moderate reliability of the test (Bulut et al., 2018), since other sensory measures did not
decline for this participant. Specifically, s/he did not develop perceived numbness and had
improved two-point discrimination scores from fair (6-8 mm) to normal (5 mm) for all digits at
this time. In addition, this person frequently experienced skin irritation prior to the study, which
may be related to the change in the Monofilament score. This finding extends previous reports of
safety in using this stimulation over 2 (N. J. Seo, M. L. Woodbury, et al., 2019) and 4 (Na Jin
Seo et al., 2019) weeks.

Continuous, Detectable, and Sustained Improvement in UE Motor Function
Second, this study extends the previous study by showing that continued use of the
stimulation during therapy beyond 2 weeks may yield additional UE improvements, as seen by
the trend of continuous UE improvement over 6 weeks. This trend of continuous UE
improvement without deterioration supports use of the stimulation over a longer rehabilitation
duration.
Specifically, every participant improved UE motor function as assessed by WMFT time
at post and follow-up compared to baseline. Mean improvement in WMFT time was greater than
MDC for post and follow-up, indicating that the improvement was beyond measurement error.
Further, mean improvement at post was retained at 1-month follow-up. This finding indicates
that the 6-week treatment resulted in detectable and sustained improvement in UE motor
function.
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While participants in the present study had improvements in WMFT time, they did not
improve on BBT. This finding contrasts the trend found in the previous 2-week study in which
improvement was more prominent in BBT than WMFT time (N. J. Seo, M. L. Woodbury, et al.,
2019). These different findings may be explained by different participant characteristics.
Specifically, participants in the present study had greater impairment at baseline compared to
those in the previous study (WMFT hand-task time mean±SD = 76±48 vs. 14±15 sec, BBT =
9±11 vs. 29±14 for the present study and previous study (N. J. Seo, M. L. Woodbury, et al.,
2019), respectively). It is possible that while our participants were able to improve WMFT time,
the improvement was not sufficient to change BBT scores. For example, two participants had
WMFT hand-task time of 114 and 115 sec at baseline. While they were able to substantially
improve the time to 75 and 86 sec at follow-up, such time is still longer than the 60 sec time limit
imposed for BBT. Consequently, their BBT scores remained at 1 from baseline to follow-up.

Clinically Meaningful/Sustained Impact on UE Use in Daily Living
Third, this study extends the previous study by showing that the improved UE motor
function seen in WMFT time translated from the laboratory to UE use in daily living in
meaningful ways. Specifically, all participants had less difficulty using their paretic hand to
perform daily tasks at post and follow-up compared to baseline, based on SIS. Mean difficulty
level lessened from “very difficult” to “somewhat difficult” for SIS-hand items, such as turning a
doorknob and opening a can. Mean difficulty level lessened from “somewhat difficult” to “a
little difficult” for SIS-ADL items, such as dressing and bathing oneself. Mean improvements in
SIS were greater than MCID, indicating that the intervention led to clinically meaningful
changes in the participants’ perceived abilities in daily living.
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Clinical meaningfulness is further highlighted by participants’ self-reported benefits. All
participants reported benefits, in a variety of domains including ADLs (e.g., self-feeding, selfcare), instrumental ADL (e.g., meal preparation), leisure, and vocation. As a result, participants
experienced increased ability to integrate into society and participate within the community, such
as dining at restaurants and mini-golfing with family. These perceived improvements in UE use
in daily living from SIS and self-reports were consistent with the objective measure using
accelerometers, showing that every participant increased the duration of paretic UE use in daily
living.

Historical Comparisons
Since this case series study did not include a control group, we performed historical
comparison to other trials in the literature. Historical comparisons show that mean UE
improvements observed in our study were greater than those in other trials with similar manual
therapy without stimulation. This comparison suggests that addition of the stimulation might
improve UE motor function and use in daily living more than therapy without stimulation.
In the historical comparisons, greater mean improvements were obtained despite no
difference and/or inferiority in baseline function, time post-stroke, and intervention length.
Specifically, for baseline, our mean WMFT time of 50 (SD=37) sec was within the ranges of the
other trials (mean±SD = 74±30 sec (Lo et al., 2010) and 17±19 sec (Winstein et al., 2016)). For
UE use in daily living, mean baseline levels were lower in our participants than other trials (51%
fewer hours of paretic UE use per day (Waddell et al., 2017); SIS-hand mean±SE = 31±14 for
our study vs. 43±6 (Birkenmeier et al., 2010), 47±3 (Lang et al., 2016); SIS-ADL mean±SE =
61±7 for our study vs. 69±4 (Birkenmeier et al., 2010), 63±2 (Lang et al., 2016)). Secondly, our
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participants were more chronic on average than the other trials (time post-stroke mean±SD
(range) = 6.2±6.6 (1.6-16) years for our study vs. 0.1±0.1 years (Winstein et al., 2016), 4.8±4.0
years (Lo et al., 2010), 1 (0.5-18.4) years (Lang et al., 2016; Waddell et al., 2017), and 3.2 (0.510) years (Birkenmeier et al., 2010)). Third, our intervention duration was shorter than or equal
to the other trials (6 weeks for our study vs. 10 weeks (Winstein et al., 2016), 12 weeks (Lo et
al., 2010), 6 weeks (Birkenmeier et al., 2010), and 8 weeks (Lang et al., 2016; Waddell et al.,
2017)).

Limitations and Future Direction
Primary limitations are the small sample and lack of control group. While the previous
study using the stimulation (N. J. Seo, M. L. Woodbury, et al., 2019) was a randomized
controlled study, the sample was still small. Therefore, a larger randomized controlled trial is
needed to confirm the efficacy of the stimulation during therapy compared to therapy without
stimulation. For intervention duration, since this study shows a trend of continuous improvement
over the 6-week intervention period, future studies may investigate at least 6 weeks of
intervention to achieve maximal effects while further examining duration effects of the
stimulation.

Conclusion
In summary, this study demonstrates that use of the stimulation during 6-week therapy
was feasible and safe, and resulted in continuous, detectable, clinically meaningful, and sustained
UE improvements, with translation to daily living, that could be greater than therapy alone as
seen in historical comparisons. The present study, together with the previous pilot randomized
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controlled study (N. J. Seo, M. L. Woodbury, et al., 2019), collectively suggest a potential that
the stimulation may be a promising therapy adjunct to improve post-stroke UE recovery beyond
therapy alone.
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Table 1
Adverse event criteria and assessment time. All criteria are compared to the baseline.
Adverse Event Criteria

Time of Assessment

Modified Ashworth scale (spasticity) increase more than 1[47]
Pain increase more than 2 on a visual analog scale 0-10
Emergence of numbness
Emergence of swelling based on wrist circumference
Assessed weekly
UE motor function score decrease more than the Minimum Detectable
Change (BBT decrease more than 5.5[35] or WMFT time increase more
than 4.36 sec[40])
Any other self-reported adverse events
Emergence of skin irritation
Monofilament or two-point discrimination increase by more than 2 levels

Assessed at pre, post,

and by a category on 1st, 2nd, and 5th digit pads

follow-up
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Figure 1. The stimulation device (circled) was worn on the paretic wrist and delivered
subthreshold vibration during task-practice therapy addressing upper extremity motor function,
such as the ability to use a screwdriver.
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Figure 2. Mean and individual scores on the Wolf Motor Function Test time (A), Box and Block
Test (B), hours of paretic upper extremity use per day measured by the accelerometer (C) and
Stroke Impact Scale - Hand (D) and Activities of Daily Living (ADL) subscales (E). Darker lines
represent the mean and lighter lines represent individual participant scores.
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Figure 3. Week-to-week change in the Wolf Motor Function Test (WMFT) time (A) and hours
of paretic upper extremity use per day measured by the accelerometer (B). The mean and
standard error of the changes are shown. The Minimum Detectable Change (MDC) for WMFT
(Lin et al., 2009) is also shown (A).
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Figure 4. Comparison to other trials. (A) Change in the Wolf Motor Function Test time
compared to other large trials with similar manual therapy of 10 (Winstein et al., 2016) and 12
(Lo et al., 2010) weeks. The mean and standard error (SE) of the change are shown. Minimum
detectable change (MDC) (Lin et al., 2009) is also shown. Changes in the Stroke Impact Scale Hand (B) and Activities of Daily Living (ADL) subscales (C) are compared to other trials with
similar manual therapy of 6 (Birkenmeier et al., 2010) and 8 (Lang et al., 2016) weeks. The mean
and SE of the change score are shown for the present study. The mean change and SE of the raw
score are shown for other trials because SE of the change was not provided. Minimum detectable
change (MDC) (Lin et al., 2010) and minimal clinically important difference (MCID) (Lin et al.,
2010) are also shown.
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Abstract
Background: Uncertain prognosis presents a challenge for therapists in determining the most
efficient course of rehabilitation treatment for individual patients. Cortical Sensorimotor network
connectivity may have prognostic utility for upper extremity motor improvement because the
integrity of the communication within the sensorimotor network forms the basis for
neuroplasticity and recovery.
Objective: To investigate if pre-intervention sensorimotor connectivity predicts post-stroke
upper extremity motor improvement following therapy.
Methods: Secondary analysis of a pilot triple-blind randomized controlled trial. Twelve chronic
stroke survivors underwent 2-week task-practice therapy, while receiving vibratory stimulation
for the treatment group and no stimulation for the control group. EEG connectivity was obtained
pre-intervention. Motor improvement was quantified as change in the Box and Block Test from
pre to post-therapy. The association between ipsilesional sensorimotor connectivity and motor
improvement was examined using regression, controlling for group. For negative control,
contralesional/interhemispheric connectivity and conventional predictors (initial clinical motor
score, age, time post-stroke, lesion volume) were examined.
Results: Greater ipsilesional sensorimotor alpha connectivity was associated with greater upper
extremity motor improvement following therapy for both groups (p<0.05). Other factors were not
significant.
Conclusion: EEG connectivity may have a prognostic utility for individual patients’ upper
extremity motor improvement following therapy in chronic stroke.
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1. Introduction
Stroke is a leading cause of long-term disability that affects nearly 800,000 people in the
United States each year.1 Of those affected by stroke, 77% experience upper extremity (UE)
impairment that reduces the individuals’ ability to perform daily tasks independently.2 However,
the extent of recovery varies widely among stroke survivors.3 Uncertain prognosis for UE motor
recovery presents a hurdle in developing personalized UE rehabilitation treatment plans for
individual patients. Improved prognosis may guide therapists to set realistic therapy goals related
to UE function and choose the maximally efficient course of treatment for their patients.
Many studies have investigated conventional predictors of UE motor recovery including
initial clinical motor score, age, time post-stroke, and lesion volume.4 Meta-analysis shows that
age, time post-stroke, and lesion volume do not predict recovery, while initial clinical motor score
is the most significant predictor.4 However, the effect sizes for initial clinical motor scores have
recently been shown to be inflated, meaning the strength of the association between initial clinical
motor scores and recovery may be overly optimistic.5,6
Sensorimotor network connectivity, measured using electroencephalography (EEG), may
have prognostic utility for UE motor recovery, because the integrity of the communication between
sensorimotor cortices forms the basis for neuroplasticity and motor recovery.7 Previous studies
have found the prognostic potential of EEG connectivity for post-stroke UE recovery.8-13 However,
previous studies have largely examined prognosis using EEG channel-based connectivity
analysis,9-13 as opposed to patient-specific source analysis.14 It is important to model EEG sources
using patient-specific brain magnetic resonance imaging (MRI) in stroke to take the lesion into
account.14 Furthermore, previous studies have investigated only one type of rehabilitation
intervention within each study.8-13 Therefore, how prognosis changes depending on the type of
rehabilitation intervention has yet to be examined.
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Therefore, the objective of this study was to investigate prognostic potential of
sensorimotor connectivity from patient-specific EEG source modeling for UE motor improvement
following two rehabilitation treatment. This study utilized data from a previously published pilot
triple-blind randomized controlled trial15 in which one group of chronic (>6 months post-stroke)
stroke survivors received UE task practice therapy and subthreshold vibratory stimulation and
the other group of chronic stroke survivors received UE task practice therapy only. It was
hypothesized that greater EEG sensorimotor connectivity prior to rehabilitation treatment is
associated with greater UE motor improvement for both groups.

2. Methods
2.1 Participants
This study entails a secondary analysis from a triple-blind randomized controlled trial.15
Participants were included if they were adults (21-80 years) at least 6-months post-stroke with
mild-to-moderate UE impairment based on Fugl-Meyer Upper Extremity Assessment scores
(30-60/66 points). Participants were excluded if they (1) exhibited cognitive impairment such as
the inability to follow 3-step instructions, (2) had botulinum toxin injection in the paretic UE within
3 months of enrollment, or (3) participate in other UE therapy sessions. A total of 12 participants
completed the study. Participants had the mean age of 62 (SD=8), mean time post-stroke of 5
(SD=5) years, and baseline FMUE score of 48 (SD=8). Baseline demographic characteristics,
including age, time post-stroke, and Fugl-Meyer Upper Extremity scores, were not significantly
different between groups.15 The study protocol was approved by the Medical University of South
Carolina’s Institutional Review Board. All participants provided written informed consent.
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2.2 Study Design
Participants were randomly assigned to the treatment or control group (n=6/group). All
participants received in-lab task-practice therapy16 for 2 hours/session, 3 sessions/week for 2
weeks. All participants also wore a vibrator (C-3 Tactor, EAI, Casselberry, FL) on the paretic
wrist during therapy.15 The treatment group received imperceptible random-frequency vibration
at 60% of the sensory threshold continuously throughout each therapy session. The control
group received no vibration. Motor improvement following therapy was quantified as change in
the Box and Block Test (∆BBT) from baseline (pre-therapy) to post-therapy. Post-therapy BBT
assessment was performed on average 6 (SD=3.6) days after the last therapy day.

2.3 EEG and MRI Acquisition
EEG was recorded at baseline. A 96-channel active electrode system (actiCAP,
BrainAmp MR plus, and Brain Vision Recorder software, Brain Vision LLC, Morrisville, NC) was
used. The position of the electrodes followed the international 10-20 system with a ground at
AFz and an average reference at FCz. The EEG cap was fitted to the subject’s head so that the
Cz electrode was positioned at the vertex. The electrode sites were hydrated using SuperVisc
gel (Brain Products GmbH, Gilching, Germany) so that the impedance was below 25 kOhms.
EEG signals were amplified, bandwidth filtered at 0.10-200 Hz and recorded at 1 kHz.
During EEG, participants were seated comfortably and performed a grip task with the
paretic hand. The task was a grip-and-relax sequence, comprised of a 2-sec-long grip and 5-6
sec rest, which was repeated 100 times, similarly with the previous literature.17 A screen
directly in front of the participants displayed visual cues through a custom LabVIEW program
(National Instruments, Austin, TX, Figure 1). Upon grip cue, Participants gripped force sensors
(Mini40, ATI Industrial Automation Inc., Apex, NC) using the thumb and index finger (Figure 1).
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Participants were given a 4 N target amount of force, which resembles the strength required to
perform daily activities. Participants practiced the grip-and-relax sequence prior to recording to
ensure they understood the instructions. Participants wore ear plugs during EEG recording to
reduce influence of outside noise.
To enable lesion-specific source modeling,14 a structural T1-weighted brain MRI scan
with an isometric 1 mm3 voxel size was obtained via the MPRAGE sequence18 using a Siemens
3T TIM Trio MRI scanner (Siemens AG, Munich, Germany). Brain MRI was obtained for 10
participants. The other 2 participants had contraindications to MRI.

2.4 EEG and MRI Analysis
The EEG data were preprocessed using MATLAB (The MathWorks, Natick, MA) and
EEGLAB toolbox.19 To remove drifts and line noise, the data were band-pass filtered at 0.5-50
Hz. Bad channels were replaced using spherical interpolation. Independent component analysis
was performed, and artifacts were removed using the ADJUST algorithm.20 Segments with
noisy data and no grip were identified from visual inspection of the EEG and force sensor data,
respectively, and excluded from further analysis, leaving mean±SD=87±18 grip trials across all
participants. Data were then segmented into epochs ranging from -2 to 4.5 sec relative to the
grip cue onset.
For source modeling, brain MRI was prepared in the following way. Cortical surfaces
were reconstructed and brain regions were segmented using FreeSurfer.21 The reconstructed
and segmented cortical surfaces were then imported into Brainstorm22 and registered with
landmarks (i.e., nasion, right/left auricular, inion, midline, anterior/posterior commissures).
Segmentation in the Desikan-Killiany atlas23 was visually inspected and shown to be incorrect
for 5 participants due to large lesions. Thus, segmentation for the regions of interest were
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manually drawn for these participants. For 2 participants with contraindication to MRI, the
Montreal Neurological Institute average brain24 was used.
The preprocessed EEG data were imported and co-registered in Brainstorm. A custom
forward head model was created for each participant using the Symmetric Boundary Element
Method.25 EEG data was projected to the head model, and source activity was computed using
the minimum norm estimation.26
Connectivity within the sensorimotor network was quantified using imaginary coherence
in Brainstorm.27 Specifically, the regions of interest were primary motor (M1), premotor, and
primary somatosensory (S1) cortices of the sensorimotor network.28 Ipsilesional sensorimotor
connectivity was the primary variable for the hypothesis testing, because ipsilesional
hemisphere function is associated with post-stroke UE motor recovery.8,9,11,12 Connectivity
among the 3 regions of interest within a hemisphere were strongly correlated (r≥0.73). Thus,
ipsilesional sensorimotor connectivity was quantified as an average coherence among M1,
premotor, and S1 within the ipsilesional hemisphere. As negative control, contralesional and
interhemispheric sensorimotor connectivity were also quantified as the average connectivity
among the regions of interest within the contralesional hemisphere and between the
hemispheres, respectively. The alpha (8-12 Hz) and beta (13-29 Hz) bands were examined
because the sensorimotor system has dominant rhythms that peak in the alpha29,30 and beta
bands31-33 in the brain. Connectivity was obtained for grip preparation (1-sec period immediately
prior to the grip cue) and grip initiation (1-sec period immediately after the grip cue onset, as
grip occurred at mean±SD=0.7±0.2 sec across all participants based on the force sensor data).
Connectivity during the grip preparation phase was used for primary hypothesis testing because
the preparation phase is associated with the planning of difficult movements,34,35 such as
precision pinch grip in stroke survivors.
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To enable additional comparison with a conventional predictor of lesion volume, lesion
volume was extracted by manually drawing the lesion on each participant’s individual T1weighted MRI scan in MRIcron.36 The stroke lesion maps were normalized into standard space.
Lesion locations for the 10 participants with MRI are summarized in Figure 2. Stroke lesion
volume was computed as the number of lesioned voxels in cubic millimeters.37

2.5 Statistical Analysis
For the primary analysis, the association between ipsilesional sensorimotor alpha/beta
connectivity during grip preparation and change in UE motor score post rehabilitation treatment
(∆BBT) was examined using regression. Regression also included the between-participant
factor of group (treatment vs. control) and the interaction between connectivity and group.
For secondary analysis, the same regression model was applied including other
covariates, namely, greater ipsilesional alpha connectivity during grip initiation,
contralesional/interhemispheric sensorimotor connectivity, and conventional predictors,
including initial function (i.e., BBT score at baseline), age, time-post stroke, and lesion volume,
as a predictor for ∆BBT. All statistical analyses were performed using SAS (SAS Institute Inc.,
Cary, NC, USA).

3. Results
Greater ipsilesional alpha connectivity during grip preparation pre-intervention was
associated with greater UE motor improvement following therapy (p=0.016, Figure 3A). Group
(p=0.241) and interaction (p=0.181) were not significant. Ipsilesional beta connectivity during
grip preparation was not significant (p=0.507).
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Secondary analysis showed that greater ipsilesional alpha connectivity during grip
initiation pre-intervention was also associated with greater UE motor improvement following
therapy (p=0.049, Figure 3B). Group (p=0.656) and interaction (p=0.823) were not significant.
For negative control, ipsilesional beta connectivity during grip initiation, contralesional/
interhemispheric alpha/beta connectivity during grip preparation/initiation, and conventional
predictors (i.e., initial BBT score, age, time-post stroke, lesion volumes) were not associated
with UE motor improvement following therapy (p>0.182).

4. Discussion
This study investigated whether sensorimotor connectivity assessed with patient-specific
EEG source modeling predicts UE motor improvement following task practice therapy with or
without subthreshold vibratory stimulation in chronic stroke. Greater ipsilesional alpha
connectivity at baseline was found to be associated with greater UE motor improvement
following both treatments. Consistent with the literature, conventional predictors4 and
contralesional/interhemispheric alpha/beta connectivity9,10 were not associated with UE motor
improvement following therapy.
Ipsilesional alpha connectivity pre-intervention may represent the extent of the brain’s
readiness for UE motor therapy and propensity for motor improvement.38 The sensorimotor
network has been shown to have dominant alpha rhythms.29,30 Alpha oscillatory activity assists
in the anticipation of upcoming sensorimotor information by activating necessary brain areas
while inhibiting other brain areas that are not needed for the given task.39 In addition, studies
have shown that alpha rhythms are implicated in internal tasks, working memory, and
attention.40-42 This evidence suggests alpha’s active role in the fundamental cognitive
operations43 that underlie the performance of motor tasks during therapy. As a result, higher
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alpha connectivity is associated with greater motor function in chronic stroke surviors.44
Furthermore, alpha connectivity assessed using magnetoencephalography (MEG) has been
shown to be linked to change in UE motor function after standard rehabilitation in stroke
survivors.38 Based on this evidence, alpha connectivity has been targeted for neurofeedbackbased modulation to enhance effectiveness of subsequent UE motor training and maximize UE
motor function.45,46 In summary, there is evidence to suggest, stroke survivors with higher
ipsilesional alpha connectivity have the capability of allocating brain resources for paretic UE
movement during therapy, thus resulting in greater potential for improving their motor function.
The positive association between ipsilesional alpha sensorimotor connectivity and motor
improvement did not differ between the two groups. No significant interaction between group
and connectivity indicates the prognostic utility of ipsilesional sensorimotor connectivity for both
treatments examined, and possibly for other types of rehabilitation treatments.
Prognosis may not be fixed per pre-intervention connectivity level; however, it could be
altered due to treatments. Specifically, motor improvements that surpassed the minimum
detectable change (5.5 for BBT)47 were observed only in stroke survivors with high ipsilesional
alpha sensorimotor connectivity in the treatment group that received subthreshold vibratory
stimulation. A meta-analysis shows using sensory stimulation in combination with UE
rehabilitation treatment enhances motor recovery.48 Likewise, in the previous pilot randomized
controlled trial for the same cohort of participants as in the present study, greater motor
improvement was observed for the treatment group using the subthreshold vibratory stimulation
than for the control group.15 Sensory stimulation has been shown to increase sensorimotor
network connectivity49 and enhance associated motor activation17 via direct neuronal projections
from the sensory to motor areas of the brain.50,51 Thus, motor improvement for a patient of a
given connectivity level may not be fixed but could be altered by adding peripheral sensory
stimulation or other treatments. Also, note that the 2-week rehabilitation treatment was likely too
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short to result in a large motor improvement and longer treatment durations may have resulted
in greater change in motor function.15
As hypothesized, ipsilesional alpha sensorimotor connectivity during the grip preparation
phase was found to be associated with UE motor improvement following therapy. This finding is
consistent with the literature that suggests a functional role of connectivity increase during the
pre-movement phase of a task34,35 that is likely attributed to the brain’s development of a motor
plan.34 In addition, ipsilesional alpha sensorimotor connectivity during grip initiation was
associated with UE motor improvement following therapy. Connectivity during grip initiation may
be related to the processes needed to execute the motor plan.34 Thus, sensorimotor
connectivity during both the grip preparation and initiation phases may hold prognostic utility for
UE motor improvement and should be considered for prediction.
The present study found prognostic potential for alpha connectivity, and not beta. This
finding is consistent with the previous MEG study.38 However, this finding differs from previous
EEG studies that found UE prognostic potential for beta8-13 and not alpha.9,10,12,13 This difference
in findings may be explained by the following. (1) Previous studies investigated subacute (1
week-6 months post-stroke)8,9 stroke survivors only and/or subacute and chronic combined,10,11
whereas the present study examined only chronic stroke survivors. Brain rhythms associated
with recovery may change over time post stroke, since the beta and theta frequencies are
dominant early after stroke,9 while alpha frequency is dominant in chronic stroke.38,44 In addition,
the inclusion of subacute stroke survivors may have introduced the confounding factor of
spontaneous recovery.52 (2) Previous studies used channel-level EEG analysis11-13 or source
modeling without taking the participant’s individual lesion into account.9,10 In contrast, the
present study performed lesion-specific source modeling. (3) All previous studies in chronic
stroke10-13 as well as the present study consist of pilot studies with small sample sizes
warranting caution in interpretation and generalizability.
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Limitations
The primary limitation is the small sample size. However, there was adequate power to
show EEG-based ipsilesional alpha connectivity is a statistically significant predictor of poststroke UE motor improvement following therapy. These results encourage a larger study to
confirm the prognostic utility of connectivity using patient-specific EEG source modeling in poststroke recovery.

5. Conclusion
This study examined the prognostic utility of ipsilesional sensorimotor connectivity using
patient-specific EEG source modeling for UE motor improvement following therapy in chronic
stroke survivors. We found that greater ipsilesional alpha connectivity measured preintervention was associated with greater UE motor improvement following task-practice therapy
with and without subthreshold vibratory stimulation. Overall, EEG-based ipsilesional
sensorimotor connectivity demonstrates potential as a prognostic biomarker and may hold utility
in predicting motor improvement from therapy in chronic stroke survivors.

Declaration of Interest Statement
N.J. Seo is an inventor of a patent regarding the investigated subthreshold vibratory stimulation.
The other authors report no conflicts of interest.

Acknowledgments
The authors would like to thank Ryan Downey for contributing to the data collection.

91

Funding

This study was possible through funding from NIH/NIGMS P20 GM109040 COBRE for Stroke
Recovery, NIH/NICHD R01 HD094731, and NIH/NCATS TL1 TR001451 and UL1 TR001450.

92

References
1.

Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019
Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56e528.

2.

Lawrence ES, Coshall C, Dundas R, et al. Estimates of the prevalence of acute stroke
impairments and disability in a multiethnic population. Stroke. 2001;32(6):1279-1284.

3.

Kent TA, Soukup VM, Fabian RH. Heterogeneity affecting outcome from acute stroke
therapy: making reperfusion worse. Stroke. 2001;32(10):2318-2327.

4.

Coupar F, Pollock A, Rowe P, Weir C, Langhorne P. Predictors of upper limb recovery
after stroke: a systematic review and meta-analysis. Clin Rehabil. 2012;26(4):291-313.

5.

Hope F, Price, Leff, Rotshtein, Bowman. Recovery after stroke: not so proportional after
all? Brain. 2019;142(1):15-22.

6.

Hawe RL, Scott SH, Dukelow SP. Taking Proportional Out of Stroke Recovery. Stroke.
2018:STROKEAHA118023006.

7.

Hosp JA, Luft AR. Cortical plasticity during motor learning and recovery after ischemic
stroke. Neural Plast. 2011;2011:871296.

8.

Guggisberg AG, Nicolo P, Cohen LG, Schnider A, Buch ER. Longitudinal Structural and
Functional Differences Between Proportional and Poor Motor Recovery After Stroke.
Neurorehabil Neural Repair. 2017;31(12):1029-1041.

9.

Nicolo P, Rizk S, Magnin C, Pietro MD, Schnider A, Guggisberg AG. Coherent neural
oscillations predict future motor and language improvement after stroke. Brain.
2015;138(Pt 10):3048-3060.

10.

Chen CC, Lee SH, Wang WJ, Lin YC, Su MC. EEG-based motor network biomarkers for
identifying target patients with stroke for upper limb rehabilitation and its construct
validity. PLoS One. 2017;12(6):e0178822.

93

11.

Wu J, Quinlan EB, Dodakian L, et al. Connectivity measures are robust biomarkers of
cortical function and plasticity after stroke. Brain. 2015;138(Pt 8):2359-2369.

12.

Zhou RJ, Hondori HM, Khademi M, et al. Predicting Gains With Visuospatial Training
After Stroke Using an EEG Measure of Frontoparietal Circuit Function. Front Neurol.
2018;9:597.

13.

Philips GR, Daly JJ, Principe JC. Topographical measures of functional connectivity as
biomarkers for post-stroke motor recovery. J Neuroeng Rehabil. 2017;14(1):67.

14.

Lai M, Demuru M, Hillebrand A, Fraschini M. A comparison between scalp- and sourcereconstructed EEG networks. Sci Rep. 2018;8(1):12269.

15.

Seo NJ, Woodbury ML, Bonilha L, et al. TheraBracelet Stimulation During Task-Practice
Therapy to Improve Upper Extremity Function After Stroke: A Pilot Randomized
Controlled Study. Phys Ther. 2019;99(3):319-328.

16.

Lang CE, Birkenmeier RL. Upper-extremity task-specific training after stroke or disability:
A manual for occupational therapy and physical therapy. AOTA Press; 2014.

17.

Seo NJ, Lakshminarayanan K, Lauer AW, et al. Use of imperceptible wrist vibration to
modulate sensorimotor cortical activity. Exp Brain Res. 2019;237(3):805-816.

18.

Brant-Zawadzki M, Gillan GD, Nitz WR. MP RAGE: a three-dimensional, T1-weighted,
gradient-echo sequence--initial experience in the brain. Radiology. 1992;182(3):769-775.

19.

Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG
dynamics including independent component analysis. J Neurosci Methods.
2004;134(1):9-21.

20.

Mognon A, Jovicich J, Bruzzone L, Buiatti M. ADJUST: An automatic EEG artifact
detector based on the joint use of spatial and temporal features. Psychophysiology.
2011;48(2):229-240.

21.

Fischl B. FreeSurfer. NeuroImage. 2012;62(2):774-781.

94

22.

Tadel F, Baillet S, Mosher JC, Pantazis D, Leahy RM. Brainstorm: A User-Friendly
Application for MEG/EEG Analysis. Comput Intell Neurosci. 2011;2011:879716.

23.

Klein A, Tourville J. 101 labeled brain images and a consistent human cortical labeling
protocol. Front Neurosci. 2012;6:171.

24.

Evans AC, Collins DL, Mills S, Brown E, Kelly R, Peters TM. 3D statistical
neuroanatomical models from 305 MRI volumes. Paper presented at: 1993 IEEE
conference record nuclear science symposium and medical imaging conference1993.

25.

Gramfort A, Papadopoulo T, Olivi E, Clerc M. OpenMEEG: opensource software for
quasistatic bioelectromagnetics. Biomed Eng Online. 2010;9:45.

26.

Baillet S MJ, Leahy RM. Electromagnetic Brain Mapping. IEEE SP MAG. 2001.

27.

Pascual-Marqui R. Coherence and phase synchronization: generalization to pairs of
multivariate time series, and removal of zero-lag contributions. arXiv preprint.
2007:arXiv:0706.1776.

28.

Lundy-Ekman L. Neuroscience: Fundamentals for Rehabilitation. Elsevier Health
Sciences; 2013.

29.

Kuhlman WN. Functional topography of the human mu rhythm. Electroencephalogr Clin
Neurophysiol. 1978;44(1):83-93.

30.

Gastaut H. [Electrocorticographic study of the reactivity of rolandic rhythm]. Rev Neurol
(Paris). 1952;87(2):176-182.

31.

Pfurtscheller G. Central beta rhythm during sensorimotor activities in man.
Electroencephalogr Clin Neurophysiol. 1981;51(3):253-264.

32.

Stolk A, Brinkman L, Vansteensel MJ, et al. Electrocorticographic dissociation of alpha
and beta rhythmic activity in the human sensorimotor system. Elife. 2019;8.

33.

Salmelin R, Hari R. Characterization of spontaneous MEG rhythms in healthy adults.
Electroencephalogr Clin Neurophysiol. 1994;91(4):237-248.

95

34.

Wheaton LA, Nolte G, Bohlhalter S, Fridman E, Hallett M. Synchronization of parietal
and premotor areas during preparation and execution of praxis hand movements. Clin
Neurophysiol. 2005;116(6):1382-1390.

35.

Wheaton LA, Shibasaki H, Hallett M. Temporal activation pattern of parietal and
premotor areas related to praxis movements. Clin Neurophysiol. 2005;116(5):12011212.

36.

Rorden C. MRIcron. Retrieved from. 2007.

37.

Wilmskoetter J, Marebwa B, Basilakos A, et al. Long-range fibre damage in small vessel
brain disease affects aphasia severity. Brain. 2019;142(10):3190-3201.

38.

Westlake KP, Hinkley LB, Bucci M, et al. Resting state alpha-band functional
connectivity and recovery after stroke. Exp Neurol. 2012;237(1):160-169.

39.

Jensen O, Mazaheri A. Shaping Functional Architecture by Oscillatory Alpha Activity:
Gating by Inhibition. Front Hum Neurosci. 2010;4(186).

40.

Cooper NR, Croft RJ, Dominey SJ, Burgess AP, Gruzelier JH. Paradox lost? Exploring
the role of alpha oscillations during externally vs. internally directed attention and the
implications for idling and inhibition hypotheses. Int J Psychophysiol. 2003;47(1):65-74.

41.

Jensen O, Gelfand J, Kounios J, Lisman JE. Oscillations in the alpha band (9-12 Hz)
increase with memory load during retention in a short-term memory task. Cereb Cortex.
2002;12(8):877-882.

42.

Kolev V, Yordanova J, Schürmann M, Başar E. Increased frontal phase-locking of eventrelated alpha oscillations during task processing. Int J Psychophysiol. 2001;39(2-3):159165.

43.

Palva S, Palva JM. New vistas for alpha-frequency band oscillations. Trends Neurosci.
2007;30(4):150-158.

44.

Dubovik S, Pignat JM, Ptak R, et al. The behavioral significance of coherent restingstate oscillations after stroke. NeuroImage. 2012;61(1):249-257.
96

45.

Mottaz A, Solca M, Magnin C, Corbet T, Schnider A, Guggisberg AG. Neurofeedback
training of alpha-band coherence enhances motor performance. Clin Neurophysiol.
2015;126(9):1754-1760.

46.

Mottaz A, Corbet T, Doganci N, et al. Modulating functional connectivity after stroke with
neurofeedback: Effect on motor deficits in a controlled cross-over study. Neuroimage
Clin. 2018;20:336-346.

47.

Chen HM, Chen CC, Hsueh IP, Huang SL, Hsieh CL. Test-retest reproducibility and
smallest real difference of 5 hand function tests in patients with stroke. Neurorehabil
Neural Repair. 2009;23(5):435-440.

48.

Conforto AB, dos Anjos SM, Bernardo WM, et al. Repetitive peripheral sensory
stimulation and upper limb performance in stroke: a systematic review and metaanalysis. Neurorehab Neural Repair. 2018;32(10):863-871.

49.

Freyer F, Reinacher M, Nolte G, Dinse HR, Ritter P. Repetitive tactile stimulation
changes resting-state functional connectivity-implications for treatment of sensorimotor
decline. Front Hum Neurosci. 2012;6:144.

50.

Jenner J, Stephens J. Cutaneous reflex responses and their central nervous pathways
studied in man. The Journal of physiology. 1982;333(1):405-419.

51.

Chen R, Ashby P. Reflex responses in upper limb muscles to cutaneous stimuli. The
Canadian journal of neurological sciences Le journal canadien des sciences
neurologiques. 1993;20(4):271-278.

52.

Cramer SC. Repairing the human brain after stroke: I. Mechanisms of spontaneous
recovery. Ann Neurol. 2008;63(3):272-287.

97

Figure 1. Experimental setup for the EEG grip task.
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Figure 2. Lesion locations for the 10 participants with an MRI. The color bar shows the number
of participants with a lesion at each area (e.g., 6 participants had a lesion in the red colored
areas).
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Figure 3. (A) Correlation between ipsilesional alpha connectivity during grip preparation and
motor improvement (change in upper extremity motor score from pre- to post-intervention). (B)
Correlation between ipsilesional alpha connectivity during grip initiation and motor improvement.
Solid lines are the fitted regression lines for the control group and dashed lines are for the
treatment group.
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Chapter 5: Conclusion
These 3 studies were conducted with the overall aim of examining the prognostic utility of
EEG in post-stroke UE motor recovery. First, through a systematic review and meta-analysis of
the literature, EEG shows potential to predict post-stroke recovery outcomes. Through the
implementation of EEG for prognosis in a pilot study with 4 chronic stroke survivors, it is feasible
to collect EEG and assess post-stroke UE motor recovery during an UE therapy program. Lastly,
through secondary analysis of a pilot randomized controlled trial with 12 chronic stroke survivors,
potential prognostic EEG-based biomarkers for UE motor recovery following therapy were
identified. Overall, the results of these studies demonstrate the potential for EEG to predict UE
motor recovery following therapy in chronic stroke and establish a foundation for further research.
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